查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930096

全球DNA合成市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

DNA Synthesis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 183 Pages | 商品交期: 請詢問到貨日

價格

DNA合成市場成長驅動因子

受科學研究、診斷和治療領域對合成DNA需求不斷成長的推動，全球DNA合成市場正經歷顯著成長。根據Fortune Business Insights的資料顯示，該市場在2025年的價值為51.9億美元，預計到2026年將達到59.5億美元。預計從2026年到2034年，該市場將以19.09%的年複合成長率成長，到2034年達到240.6億美元，這反映了合成DNA在基因治療、分子診斷和個人化醫療領域日益廣泛的應用。北美在2025年佔據市場主導地位，市場佔有率高達54.61%。這得益於強大的研發基礎設施、精準醫療的高普及率，以及領先企業積極拓展服務和推出創新產品的努力。

DNA合成是指人工合成DNA分子，包括寡核苷酸、基因及DNA片段。這些合成DNA產品能夠用於開發新藥、疫苗、遺傳疾病基因療法以及分子診斷工具，例如PCR檢測和核酸感測器。慢性病、遺傳疾病和罕見疾病的日益普遍、醫療保健成本的不斷上漲以及人們對個人化治療意識的增強，推動全球對合成DNA的需求。

市場趨勢

技術進步是市場成長的關鍵驅動力。各公司正致力於開發更快、更準確、更經濟高效的DNA合成方法，例如自動化微流控系統，以減少處理時間和人力需求。例如，2023年8月，Atantares公司籌集了1390萬美元，用於開發一種用於高通量酶促DNA合成的分子晶片，這體現了自動化和效率提升的趨勢。

在新冠疫情期間，由於分子診斷檢測和疫苗研發的迫切需求，合成DNA的需求激增。疫情過後，市場趨於穩定，但對精準醫療和基因治療的日益關注，使其保持了強勁的成長動力。

市場成長驅動因素

市場成長的驅動因素是DNA合成技術在新型療法、分子診斷、研發領域的廣泛應用。特別是基因合成，由於其可客製化的應用，對製藥和生物技術公司的需求不斷成長。例如，預計到2026年，基因合成領域將佔整個市場的74.31%。寡核苷酸合成也因其在診斷、治療和基因治療中的應用而備受關注。

醫療保健支出和精準醫療投資進一步推動了市場成長。基因合成技術能夠針對癌症和遺傳疾病等疾病提供個人化治療，這與英國等國的政府政策相符。到2025年，英國的公共研發支出將達到273.6億美元。

市場限制因子

儘管市場成長迅速，但仍面臨諸多挑戰，例如缺乏明確的監管框架和熟練的實驗室人員短缺。例如，2022年9月，歐洲藥品管理局（EMA）宣布需要製定合成寡核苷酸指南，這反映出監管方面的不確定性，可能會延遲產品上市。

市場區隔分析

依產品/服務劃分：服務細分市場在2026年將佔據72.76%的市場佔有率，這主要得益於提供高純度、高性價比客製化DNA解決方案的企業。產品領域（包括儀器、試劑和耗材）也佔據了相當大的佔有率，這主要得益於Telesis Bio Inc.於2023年5月推出的 "BioXp Select DNA克隆試劑盒" 等新產品的推動。

依類型劃分：基因合成佔據最大佔有率，這主要歸功於其可自訂的序列以及科研機構和行業的高需求。寡核苷酸合成的成長主要得益於其在診斷、治療和分子生物學領域日益廣泛的應用。

依應用劃分：診斷領域將在2026年佔據領先地位，市場佔有率達50.26%，這主要得益於癌症和傳染病分子診斷的推動。治療領域由於基因治療和疫苗的研發而成長，而研發領域則透過藥物發現、克隆和基因編輯等技術持續擴張。

依最終用戶劃分：製藥和生物技術公司佔據最大佔有率，它們利用合成DNA開發新型療法和基因療法。合約研究組織/合約研發生產組織（CRO/CDMO）緊隨其後，提供專業化的生產和服務。學術和研究機構對此類產品的採用率也不斷提高。

區域趨勢

北美將在2025年以28.3億美元的市場規模引領市場，預計到2026年將成長至32.2億美元，這主要得益於慢性病和遺傳病的高發生率、先進的研究基礎設施以及個性化醫療的不斷發展。光是美國市場預計到2026年就將達到30.3億美元。歐洲也佔了相當大的市場佔有率，其中英國和德國預計分別達到2.2億美元和3.2億美元，這得益於雙方強大的研發合作。亞太地區預計將實現最高的年複合成長率，其中中國、日本和印度預計到2026年將分別達到4.3億美元、2.4億美元和1.3億美元，這主要得益於生物技術基礎設施的擴張、研究合作的加強以及合成DNA技術的日益普及。拉丁美洲和中東及非洲地區預計將實現溫和成長，這主要得益於各國政府主導的加強生物技術研究的措施。

主要公司及趨勢

主要市場參與者包括Thermo Fisher Scientific、Integrated DNA Technologies、GenScript、Eurofins Scientific、Azenta、Twist Bioscience。各公司正致力於策略合作、設施擴建和新服務開發。例如，2023年11月，Twist Biosciences推出了 "Twist Express Genes" ，提供快速基因合成和加速遞送服務。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • DNA合成技術步驟
  • 關鍵產業趨勢：併購、業務合作等
  • 新產品發布
  • 新冠疫情對DNA合成的影響合成市場

第5章 全球DNA合成市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品/服務劃分
    • 產品
      • 設備
      • 試劑及耗材
    • 服務
  • 市場分析、洞察與預測：依類型
    • 寡核苷酸合成
    • 基因合成
  • 市場分析、洞察與預測：依應用
    • 診斷
      • 傳染病
      • 癌症
      • 其他
    • 治療
      • 基因治療
      • 預防醫藥
      • 其他
    • 研發
      • 克隆技術、基因編輯
      • 藥物發現與開發
      • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥和生技公司
    • 合約研究組織（CRO）與合約開發與生產組織（CDMO）
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美DNA合成市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 美國
    • 加拿大

第7章 歐洲DNA合成市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第8章 亞太地區DNA合成市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他地區亞太地區

第9章 拉丁美洲DNA合成市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲DNA合成市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司公司簡介
    • Thermo Fisher Scientific Inc.
    • Integrated DNA Technologies, Inc.（Danaher）
    • Eurofins Scientific
    • GenScript
    • Azenta, Inc.
    • LGC Limited
    • Biomatik
    • Telesis Bio Inc.
    • Twist Bioscience
    • Bioneer Corporation
Product Code: FBI109799

Growth Factors of DNA synthesis Market

The global DNA synthesis market is witnessing significant growth driven by the rising demand for synthetic DNA in research, diagnostics, and therapeutic applications. According to Fortune Business Insights, the market was valued at USD 5.19 billion in 2025, and it is expected to grow to USD 5.95 billion in 2026. With an anticipated CAGR of 19.09% from 2026 to 2034, the market is projected to reach USD 24.06 billion by 2034, reflecting the increasing adoption of synthetic DNA for gene therapy, molecular diagnostics, and personalized medicine. North America dominated the market in 2025, holding 54.61% market share, due to robust R&D infrastructure, high adoption of precision medicine, and active initiatives by leading companies to expand services and launch innovative products.

DNA synthesis involves the artificial creation of DNA molecules, including oligonucleotides, genes, and DNA fragments. These synthetic DNA products enable the development of new drugs, vaccines, gene therapies for genetic disorders, and molecular diagnostic tools such as PCR assays and nucleic-acid-based sensors. The rising prevalence of chronic, genetic, and rare diseases, along with increased healthcare expenditure and awareness of personalized treatment, is propelling demand for synthetic DNA globally.

Market Trends

Technological advancements have been a significant driver of market growth. Companies are focusing on faster, more accurate, and cost-effective DNA synthesis methods, including automated microfluidics systems, which reduce turnaround time and labor requirements. For example, in August 2023, Atantares raised USD 13.9 million to develop molecular chips for high-throughput enzymatic DNA synthesis, demonstrating the trend toward automation and efficiency.

During the COVID-19 pandemic, demand for synthetic DNA surged due to the urgent need for molecular diagnostic tests and vaccine development. Post-pandemic, the market stabilized, but the increased focus on precision medicine and gene-based therapeutics has maintained strong growth momentum.

Market Growth Factors

The growing use of DNA synthesis in novel therapeutics, molecular diagnostics, and R&D initiatives is driving market expansion. Gene synthesis is particularly in demand due to its customizable applications for pharmaceutical and biotechnology companies. For instance, the gene synthesis segment accounted for 74.31% of the market in 2026. Oligonucleotide synthesis is also gaining traction due to its use in diagnostics, therapeutics, and gene therapy.

Healthcare spending and investments in precision medicine are further enhancing market growth. Gene synthesis allows tailored treatments for diseases such as cancer and genetic disorders, aligning with government initiatives in countries like the U.K., where public R&D spending is projected to reach USD 27.36 billion by 2025.

Market Restraints

Despite rapid growth, the market faces challenges, including a lack of clear regulatory frameworks and a shortage of skilled laboratory personnel. For instance, in September 2022, the European Medicines Agency highlighted the need for guidelines on synthetic oligonucleotides, reflecting regulatory uncertainties that may slow product launches.

Segmentation Analysis

By Product & Service: The services segment dominated the market with 72.76% share in 2026, driven by providers offering high-purity, cost-effective, and customized DNA solutions. The products segment, including instruments and reagents & consumables, also holds a significant portion, bolstered by new launches such as the BioXp Select DNA Cloning kit by Telesis Bio Inc. in May 2023.

By Type: Gene synthesis holds the largest share due to customizable sequences and high demand from research institutions and industry. Oligonucleotide synthesis is growing due to increasing use in diagnostics, therapeutics, and molecular biology applications.

By Application: The diagnostics segment dominated in 2026 with 50.26% market share, driven by molecular diagnostics for diseases such as cancer and infectious diseases. The therapeutics segment is growing due to gene therapy and vaccine development, while R&D continues to expand through drug discovery, cloning, and gene editing initiatives.

By End-User: Pharmaceutical and biotechnology companies hold the largest share, leveraging synthetic DNA for novel therapeutics and gene therapy development. Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) follow closely, offering specialized production and services. Academic and research institutes are also increasing adoption.

Regional Insights

North America dominated with USD 2.83 billion in 2025, growing to USD 3.22 billion in 2026, driven by high prevalence of chronic and genetic diseases, advanced research infrastructure, and increasing personalized medicine initiatives. The U.S. market alone is projected at USD 3.03 billion in 2026. Europe holds a significant market share, with the U.K. and Germany projected to reach USD 0.22 billion and USD 0.32 billion, respectively, in 2026, supported by strong R&D collaborations. The Asia Pacific region is anticipated to witness the highest CAGR, with China, Japan, and India projected at USD 0.43 billion, USD 0.24 billion, and USD 0.13 billion, respectively, in 2026, due to growing biotech infrastructure, research collaborations, and increasing adoption of synthetic DNA technologies. Latin America and the Middle East & Africa are expected to grow moderately, driven by government initiatives to enhance biotechnology research.

Key Players & Developments

Prominent market players include Thermo Fisher Scientific, Integrated DNA Technologies, GenScript, Eurofins Scientific, Azenta, and Twist Bioscience. Companies focus on strategic collaborations, facility expansions, and new service launches. For instance, in November 2023, Twist Bioscience launched Twist Express Genes, offering rapid gene synthesis with accelerated delivery.

Conclusion

The global DNA synthesis market is set for robust growth, expanding from USD 5.19 billion in 2025 to USD 24.06 billion by 2034, driven by technological advancements, growing demand in diagnostics, therapeutics, and research, and increasing investments in synthetic biology. With innovations in gene synthesis, growing adoption of oligonucleotides, and regional expansion, the market is poised to play a critical role in precision medicine and the future of biotechnology worldwide.

Segmentation By Product & Service

  • Products
    • Instruments
    • Reagents & Consumables
  • Services

By Type

  • Oligonucleotide Synthesis
  • Gene Synthesis

By Application

  • Diagnostics
    • Infectious Diseases
    • Cancer
    • Others
  • Therapeutics
    • Gene Therapy
    • Preventive Medicine
    • Others
  • Research & Development
    • Cloning and Gene Editing
    • Drug Discovery & Development
    • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
  • Others

By Region

  • North America (By Product & Service, By Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Developments in the DNA Synthesis
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. New Product Launches
  • 4.4. Impact of COVID-19 on the DNA Synthesis Market

5. Global DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product & Service
    • 5.1.1. Products
      • 5.1.1.1. Instruments
      • 5.1.1.2. Reagents & Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Oligonucleotide Synthesis
    • 5.2.2. Gene Synthesis
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Diagnostics
      • 5.3.1.1. Infectious Diseases
      • 5.3.1.2. Cancer
      • 5.3.1.3. Others
    • 5.3.2. Therapeutics
      • 5.3.2.1. Gene Therapy
      • 5.3.2.2. Preventive Medicine
      • 5.3.2.3. Others
    • 5.3.3. Research & Development
      • 5.3.3.1. Cloning and Gene Editing
      • 5.3.3.2. Drug Discovery & Development
      • 5.3.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product & Service
    • 6.1.1. Products
      • 6.1.1.1. Instruments
      • 6.1.1.2. Reagents & Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Oligonucleotide Synthesis
    • 6.2.2. Gene Synthesis
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Diagnostics
      • 6.3.1.1. Infectious Diseases
      • 6.3.1.2. Cancer
      • 6.3.1.3. Others
    • 6.3.2. Therapeutics
      • 6.3.2.1. Gene Therapy
      • 6.3.2.2. Preventive Medicine
      • 6.3.2.3. Others
    • 6.3.3. Research & Development
      • 6.3.3.1. Cloning and Gene Editing
      • 6.3.3.2. Drug Discovery & Development
      • 6.3.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product & Service
    • 7.1.1. Products
      • 7.1.1.1. Instruments
      • 7.1.1.2. Reagents & Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Oligonucleotide Synthesis
    • 7.2.2. Gene Synthesis
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Diagnostics
      • 7.3.1.1. Infectious Diseases
      • 7.3.1.2. Cancer
      • 7.3.1.3. Others
    • 7.3.2. Therapeutics
      • 7.3.2.1. Gene Therapy
      • 7.3.2.2. Preventive Medicine
      • 7.3.2.3. Others
    • 7.3.3. Research & Development
      • 7.3.3.1. Cloning and Gene Editing
      • 7.3.3.2. Drug Discovery & Development
      • 7.3.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product & Service
    • 8.1.1. Products
      • 8.1.1.1. Instruments
      • 8.1.1.2. Reagents & Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Oligonucleotide Synthesis
    • 8.2.2. Gene Synthesis
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Diagnostics
      • 8.3.1.1. Infectious Diseases
      • 8.3.1.2. Cancer
      • 8.3.1.3. Others
    • 8.3.2. Therapeutics
      • 8.3.2.1. Gene Therapy
      • 8.3.2.2. Preventive Medicine
      • 8.3.2.3. Others
    • 8.3.3. Research & Development
      • 8.3.3.1. Cloning and Gene Editing
      • 8.3.3.2. Drug Discovery & Development
      • 8.3.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product & Service
    • 9.1.1. Products
      • 9.1.1.1. Instruments
      • 9.1.1.2. Reagents & Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Oligonucleotide Synthesis
    • 9.2.2. Gene Synthesis
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Diagnostics
      • 9.3.1.1. Infectious Diseases
      • 9.3.1.2. Cancer
      • 9.3.1.3. Others
    • 9.3.2. Therapeutics
      • 9.3.2.1. Gene Therapy
      • 9.3.2.2. Preventive Medicine
      • 9.3.2.3. Others
    • 9.3.3. Research & Development
      • 9.3.3.1. Cloning and Gene Editing
      • 9.3.3.2. Drug Discovery & Development
      • 9.3.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product & Service
    • 10.1.1. Products
      • 10.1.1.1. Instruments
      • 10.1.1.2. Reagents & Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Oligonucleotide Synthesis
    • 10.2.2. Gene Synthesis
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Diagnostics
      • 10.3.1.1. Infectious Diseases
      • 10.3.1.2. Cancer
      • 10.3.1.3. Others
    • 10.3.2. Therapeutics
      • 10.3.2.1. Gene Therapy
      • 10.3.2.2. Preventive Medicine
      • 10.3.2.3. Others
    • 10.3.3. Research & Development
      • 10.3.3.1. Cloning and Gene Editing
      • 10.3.3.2. Drug Discovery & Development
      • 10.3.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Integrated DNA Technologies, Inc. (Danaher)
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Eurofins Scientific
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. GenScript
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Azenta, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. LGC Limited
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Biomatik
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Telesis Bio Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Twist Bioscience
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Bioneer Corporation
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 02: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 03: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 04: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 05: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 06: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 07: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 08: Global DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 09: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 10: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 11: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 12: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 13: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 15: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 16: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 17: North America DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 18: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 19: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 20: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 21: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 24: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 25: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 26: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 27: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 28: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 29: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 30: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 31: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 32: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 33: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 34: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 35: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 36: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 37: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 38: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 39: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 40: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 42: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 43: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 44: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 45: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 46: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
  • Table 47: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 48: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 49: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 50: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
  • Table 51: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
  • Table 52: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
  • Table 53: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 54: Middle East & Africa DNA Synthesis Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 01: Global DNA Synthesis Market Revenue Breakdown (USD billion, %), by Region, 2025 & 2034
  • Figure 02: Global DNA Synthesis Market Value Share (%), By Product & Service, 2025 & 2034
  • Figure 03: Global DNA Synthesis Market Value Share (%), By Type, 2025 & 2034
  • Figure 04: Global DNA Synthesis Market Value Share (%), By Application, 2025 & 2034
  • Figure 05: Global DNA Synthesis Market Value Share (%), By End-user, 2025 & 2034
  • Figure 06: Global DNA Synthesis Market Value Share (%), By Region, 2025 & 2034
  • Figure 07: North America DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 08: North America DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 09: North America DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 10: North America DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 11: North America DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 13: North America DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 14: North America DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 15: North America DNA Synthesis Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America DNA Synthesis Market Value Share (%), By Country, 2025
  • Figure 17: Europe DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 18: Europe DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 19: Europe DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 20: Europe DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 21: Europe DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 23: Europe DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 24: Europe DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 25: Europe DNA Synthesis Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 26: Europe DNA Synthesis Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 27: Asia Pacific DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 28: Asia Pacific DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 29: Asia Pacific DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 30: Asia Pacific DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 31: Asia Pacific DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 34: Asia Pacific DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 35: Asia Pacific DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 36: Asia Pacific DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 37: Latin America DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 38: Latin America DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 39: Latin America DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 40: Latin America DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 41: Latin America DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Latin America DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 43: Latin America DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 44: Latin America DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 45: Latin America DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 46: Latin America DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 47: Middle East & Africa DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
  • Figure 48: Middle East & Africa DNA Synthesis Market Value Share (%), By Product & Service, 2025
  • Figure 49: Middle East & Africa DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
  • Figure 50: Middle East & Africa DNA Synthesis Market Value Share (%), By Type, 2025
  • Figure 51: Middle East & Africa DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa DNA Synthesis Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 54: Middle East & Africa DNA Synthesis Market Value Share (%), By End-user, 2025
  • Figure 55: Middle East & Africa DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 56: Middle East & Africa DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 57: Global DNA Synthesis Market Share Analysis, By Company, 2025